| Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies G Turrini, M Purgato, F Ballette, M Nosè, G Ostuzzi, C Barbui International journal of mental health systems 11, 1-14, 2017 | 377 | 2017 |
| Antidepressants for the treatment of depression in people with cancer G Ostuzzi, F Matcham, S Dauchy, C Barbui, M Hotopf Cochrane Database of Systematic Reviews, 2018 | 292 | 2018 |
| Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review C Barbui, M Purgato, J Abdulmalik, C Acarturk, J Eaton, C Gastaldon, ... The Lancet Psychiatry 7 (2), 162-172, 2020 | 198 | 2020 |
| Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis G Turrini, M Purgato, C Acarturk, M Anttila, T Au, F Ballette, M Bird, ... Epidemiology and psychiatric sciences 28 (4), 376-388, 2019 | 192 | 2019 |
| Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations G Ostuzzi, D Papola, C Gastaldon, G Schoretsanitis, F Bertolini, ... Focus 18 (4), 466-481, 2020 | 115 | 2020 |
| Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies G Ostuzzi, I Bighelli, R So, TA Furukawa, C Barbui Schizophrenia research 183, 10-21, 2017 | 87 | 2017 |
| Vortioxetine for depression in adults M Koesters, G Ostuzzi, G Guaiana, J Breilmann, C Barbui Cochrane Database of Systematic Reviews, 2017 | 85 | 2017 |
| Antipsychotic use and risk of life‐threatening medical events: umbrella review of observational studies D Papola, G Ostuzzi, C Gastaldon, GP Morgano, E Dragioti, AF Carvalho, ... Acta Psychiatrica Scandinavica 140 (3), 227-243, 2019 | 74 | 2019 |
| Effectiveness of a WHO Self‐Help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial C Acarturk, E Uygun, Z Ilkkursun, K Carswell, F Tedeschi, M Batu, S Eskici, ... World Psychiatry 21 (1), 88-95, 2022 | 65 | 2022 |
| Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis G Ostuzzi, F Bertolini, C Del Giovane, F Tedeschi, C Bovo, C Gastaldon, ... American Journal of Psychiatry 178 (5), 424-436, 2021 | 65 | 2021 |
| Efficacy of interventions to reduce coercive treatment in mental health services: umbrella review of randomised evidence C Barbui, M Purgato, J Abdulmalik, JM Caldas-de-Almeida, J Eaton, ... The British Journal of Psychiatry 218 (4), 185-195, 2021 | 64 | 2021 |
| Implementation of treatment guidelines for specialist mental health care I Bighelli, G Ostuzzi, F Girlanda, A Cipriani, T Becker, M Koesters, ... Cochrane Database of Systematic Reviews, 2016 | 64 | 2016 |
| Effectiveness of self-help plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial M Purgato, K Carswell, F Tedeschi, C Acarturk, M Anttila, T Au, M Bajbouj, ... Psychotherapy and psychosomatics 90 (6), 403-414, 2021 | 63 | 2021 |
| Antipsychotic dose mediates the association between polypharmacy and corrected QT interval C Barbui, I Bighelli, G Carrà, M Castellazzi, C Lucii, G Martinotti, M Nosè, ... PLoS One 11 (2), e0148212, 2016 | 63 | 2016 |
| Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature AD Meid, I Bighelli, S Mächler, G Mikus, G Carrà, M Castellazzi, C Lucii, ... Therapeutic advances in psychopharmacology 7 (12), 251-264, 2017 | 60 | 2017 |
| Can we identify the active ingredients of behaviour change interventions for coronary heart disease patients? A systematic review and meta-analysis L Goodwin, G Ostuzzi, N Khan, MH Hotopf, R Moss-Morris PloS one 11 (4), e0153271, 2016 | 59 | 2016 |
| Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study M Nose, I Bighelli, M Castellazzi, G Martinotti, G Carrà, C Lucii, G Ostuzzi, ... Epidemiology and psychiatric sciences 25 (6), 532-540, 2016 | 54 | 2016 |
| Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants G Ostuzzi, F Bertolini, F Tedeschi, G Vita, P Brambilla, L Del Fabro, ... World Psychiatry 21 (2), 295-307, 2022 | 53 | 2022 |
| Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches G Ostuzzi, C Gastaldon, D Papola, A Fagiolini, S Dursun, D Taylor, ... Therapeutic Advances in Psychopharmacology 10, 2045125320942703, 2020 | 50 | 2020 |
| Factors associated with first-versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy G Ostuzzi, MA Mazzi, S Terlizzi, F Bertolini, A Aguglia, F Bartoli, ... PloS one 13 (8), e0201371, 2018 | 50 | 2018 |
